532 related articles for article (PubMed ID: 31709463)
1. Guideline on the use of iodinated contrast media in patients with kidney disease 2018.
Isaka Y; Hayashi H; Aonuma K; Horio M; Terada Y; Doi K; Fujigaki Y; Yasuda H; Sato T; Fujikura T; Kuwatsuru R; Toei H; Murakami R; Saito Y; Hirayama A; Murohara T; Sato A; Ishii H; Takayama T; Watanabe M; Awai K; Oda S; Murakami T; Yagyu Y; Joki N; Komatsu Y; Miyauchi T; Ito Y; Miyazawa R; Kanno Y; Ogawa T; Hayashi H; Koshi E; Kosugi T; Yasuda Y;
Clin Exp Nephrol; 2020 Jan; 24(1):1-44. PubMed ID: 31709463
[No Abstract] [Full Text] [Related]
2. Imaging-guided percutaneous coronary intervention with ultra-low contrast angiographic control for patients at extreme risk of contrast induced nephropathy.
Pyka Ł; Hawranek M; Wilczek K; Piegza J; Szkodzinski J; Lekston A; Gąsior M
Cardiol J; 2019; 26(6):796-798. PubMed ID: 31970738
[No Abstract] [Full Text] [Related]
3. The Bermuda triangle: Chronic kidney disease, contrast-induced nephropathy, and atrial fibrillation.
Elserafy AS
Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):72-74. PubMed ID: 29033366
[No Abstract] [Full Text] [Related]
4. Guidelines for treatment of renal injury during cancer chemotherapy 2016.
Horie S; Oya M; Nangaku M; Yasuda Y; Komatsu Y; Yanagita M; Kitagawa Y; Kuwano H; Nishiyama H; Ishioka C; Takaishi H; Shimodaira H; Mogi A; Ando Y; Matsumoto K; Kadowaki D; Muto S
Clin Exp Nephrol; 2018 Feb; 22(1):210-244. PubMed ID: 28856465
[No Abstract] [Full Text] [Related]
5. Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery.
Rahim HM; Flattery E; Gkargkoulas F; Maehara A; Mintz GS; Hardy MA; Cohen DJ; Dube GK; Crew RJ; Mohan S; Radhakrishnan J; Ratner LE; Moses JW; Ben-Yehuda O; Kirtane AJ; Stone GW; Leon MB; Karmpaliotis D; Ali ZA
Coron Artery Dis; 2019 Aug; 30(5):346-351. PubMed ID: 31094895
[TBL] [Abstract][Full Text] [Related]
6. [Contrast medium-induced acute kidney injury-Consensus paper of the working group "Heart and Kidney" of the German Cardiac Society and the German Society of Nephrology].
Latus J; Schwenger V; Schlieper G; Reinecke H; Hoyer J; Persson PB; Remppis BA; Mahfoud F
Internist (Berl); 2021 Jan; 62(1):111-120. PubMed ID: 33349899
[TBL] [Abstract][Full Text] [Related]
7. Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial.
Garcia S; Bhatt DL; Gallagher M; Jneid H; Kaufman J; Palevsky PM; Wu H; Weisbord SD;
JACC Cardiovasc Interv; 2018 Nov; 11(22):2254-2261. PubMed ID: 30466822
[TBL] [Abstract][Full Text] [Related]
8. Minimizing the risk of contrast-induced nephropathy and hemodynamic collapse during chronic total occlusion percutaneous coronary intervention with a percutaneous left ventricular assist device.
Regazzoli D; Hachinohe D; Demir OM; Carlino M; Lemoine J; Mitomo S; Poletti E; Amor M; Colombo A; Azzalini L
Cardiovasc Revasc Med; 2018 Sep; 19(6):712-716. PubMed ID: 29506964
[TBL] [Abstract][Full Text] [Related]
9. [Acute kidney injury: progress in diagnosis and treatments. Topics: IV. Pathophysiology and treatments: 1. Contrast-induced acute kidney injury].
Isaka Y; Rakugi H
Nihon Naika Gakkai Zasshi; 2014 May; 103(5):1074-80. PubMed ID: 25026776
[No Abstract] [Full Text] [Related]
10. Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.
Davenport MS; Perazella MA; Yee J; Dillman JR; Fine D; McDonald RJ; Rodby RA; Wang CL; Weinreb JC
Radiology; 2020 Mar; 294(3):660-668. PubMed ID: 31961246
[TBL] [Abstract][Full Text] [Related]
11. Points to remember: practical clinical pearls for the practicing clinician.
Olivero JJ
Methodist Debakey Cardiovasc J; 2013; 9(1):60. PubMed ID: 23519556
[No Abstract] [Full Text] [Related]
12. A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury.
Panagiotou A; Trendelenburg M; Heijnen IAFM; Moser S; Bonati LH; Breidthardt T; Fahrni G; Kaiser C; Jeger R; Osthoff M
JACC Cardiovasc Interv; 2020 Apr; 13(7):833-842. PubMed ID: 32171721
[TBL] [Abstract][Full Text] [Related]
13. Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.
Gurm HS; Mavromatis K; Bertolet B; Kereiakes DJ; Amin AP; Shah AP; Hanzel GS; Rao S; Thomas JL; Kumar G
Catheter Cardiovasc Interv; 2019 Jun; 93(7):1228-1235. PubMed ID: 30393942
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Minimize Iodinated Contrast Volume in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Interventions.
Lee SR; Dardik A; Chaar CIO
Ann Vasc Surg; 2021 May; 73():490-495. PubMed ID: 33556507
[TBL] [Abstract][Full Text] [Related]
15. Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018.
Isaka Y; Hayashi H; Aonuma K; Horio M; Terada Y; Doi K; Fujigaki Y; Yasuda H; Sato T; Fujikura T; Kuwatsuru R; Toei H; Murakami R; Saito Y; Hirayama A; Murohara T; Sato A; Ishii H; Takayama T; Watanabe M; Awai K; Oda S; Murakami T; Yagyu Y; Joki N; Komatsu Y; Miyauchi T; Ito Y; Miyazawa R; Kanno Y; Ogawa T; Hayashi H; Koshi E; Kosugi T; Yasuda Y; ; ;
Circ J; 2019 Nov; 83(12):2572-2607. PubMed ID: 31708511
[No Abstract] [Full Text] [Related]
16. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
[TBL] [Abstract][Full Text] [Related]
17. [SICI-GISE/SIN Consensus document: Contrast-induced acute kidney injury in interventional cardiology].
Ronco F; Azzalini L; Briguori C; Cosmai L; D'Amico M; Di Luca M; Esposito G; Granatelli A; Maddestra N; De Marco F; La Manna A; Maioli M; Musumeci G; Tarantino F; Venturelli C; Brunori G; Tarantini G
G Ital Cardiol (Rome); 2019 Sep; 20(9 Suppl 1):29S-43S. PubMed ID: 31593189
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of high flow-volume intermittent hemodiafiltration during and after intervention to prevent contrast-induced nephropathy in patients with advanced chronic kidney disease: A pilot study.
Oyamada N; Hamanaka I; Fujioka A; Iwasaku T; Minami T; Fujie H; Ueda K
Catheter Cardiovasc Interv; 2020 Nov; 96(6):1174-1181. PubMed ID: 31802610
[TBL] [Abstract][Full Text] [Related]
19. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
[TBL] [Abstract][Full Text] [Related]
20. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
